Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of NOVOEIGHT is substantial. |
Clinical Added Value
| no clinical added value |
NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments. |
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
0wXmuhm5ecqcBuSB
